CD8A and amyotrophic lateral sclerosis: The key immune alterations observed in ALS include reduced regulatory T cells (Tregs), expansion of senescent CD8+ terminally differentiated effector memory (TEMRA) cells, and persistent activation of microglia and astrocytes within the central nervous system (CNS) [19, 20].